Evalaroza, Rosevil .

HRN: 21-88-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2022
CEFUROXIME 1.5GM (VIAL)
09/09/2022
09/16/2022
IV
1.5 G
Q8H
Soft Tissue Injuries
Waiting Final Action 
09/09/2022
MUPIROCIN 2%, 15G (TUBE)
09/09/2022
09/16/2022
SKIN
2 %
BID
Multiple Soft Tissue Injuries
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: